157 related articles for article (PubMed ID: 36774339)
21. Mesenchymal Stem Cell-derived Extracellular Vesicles Transmitting MicroRNA-34a-5p Suppress Tumorigenesis of Colorectal Cancer Through c-MYC/DNMT3a/PTEN Axis.
Zhao J; Lin H; Huang K
Mol Neurobiol; 2022 Jan; 59(1):47-60. PubMed ID: 34623601
[TBL] [Abstract][Full Text] [Related]
22. CUX2/KDM5B/SOX17 Axis Affects the Occurrence and Development of Breast Cancer.
Li L; Zhu G; Tan K; Jiang L; Li Y; Zhu X; Lin Z; Zhang X; Chen J; Ma C
Endocrinology; 2022 Sep; 163(9):. PubMed ID: 35881915
[TBL] [Abstract][Full Text] [Related]
23. Low shear stress induces ERK nuclear localization and YAP activation to control the proliferation of breast cancer cells.
Qin X; Li J; Sun J; Liu L; Chen D; Liu Y
Biochem Biophys Res Commun; 2019 Mar; 510(2):219-223. PubMed ID: 30685085
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of dermatopontin and its implications for testicular dysfunction in mice.
Cai J; Liu W; Hao J; Chen M; Li G
Mol Med Rep; 2016 Mar; 13(3):2431-8. PubMed ID: 26861869
[TBL] [Abstract][Full Text] [Related]
25. YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients.
Xia Y; Chang T; Wang Y; Liu Y; Li W; Li M; Fan HY
PLoS One; 2014; 9(3):e91770. PubMed ID: 24622501
[TBL] [Abstract][Full Text] [Related]
26. miR-26a-5p Suppresses Wnt/
Yu J; Ge Z; Chen S; Li S; Zhang X; Hu J; Guo W; Wang Y
Dis Markers; 2022; 2022():7926483. PubMed ID: 35860691
[TBL] [Abstract][Full Text] [Related]
27. SPOCK1/SIX1axis promotes breast cancer progression by activating AKT/mTOR signaling.
Xu M; Zhang X; Zhang S; Piao J; Yang Y; Wang X; Lin Z
Aging (Albany NY); 2020 Dec; 13(1):1032-1050. PubMed ID: 33293473
[TBL] [Abstract][Full Text] [Related]
28. Dermatopontin augments angiogenesis and modulates the expression of transforming growth factor beta 1 and integrin alpha 3 beta 1 in endothelial cells.
Krishnaswamy VR; Balaguru UM; Chatterjee S; Korrapati PS
Eur J Cell Biol; 2017 May; 96(3):266-275. PubMed ID: 28336087
[TBL] [Abstract][Full Text] [Related]
29. SYNPO2 suppresses hypoxia-induced proliferation and migration of colorectal cancer cells by regulating YAP-KLF5 axis.
OuYang C; Xie Y; Fu Q; Xu G
Tissue Cell; 2021 Dec; 73():101598. PubMed ID: 34333382
[TBL] [Abstract][Full Text] [Related]
30. Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer.
Wang L; Wang C; Tao Z; Zhao L; Zhu Z; Wu W; He Y; Chen H; Zheng B; Huang X; Yu Y; Yang L; Liang G; Cui R; Chen T
J Exp Clin Cancer Res; 2019 Nov; 38(1):460. PubMed ID: 31703744
[TBL] [Abstract][Full Text] [Related]
31. DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation.
Zhou Y; Yang Z; Zhang H; Li H; Zhang M; Wang H; Zhang M; Qiu P; Zhang R; Liu J
Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166353. PubMed ID: 35063646
[TBL] [Abstract][Full Text] [Related]
32. Aberrant promoter hypermethylation inhibits RGMA expression and contributes to tumor progression in breast cancer.
Li Y; Liu HT; Chen X; Wang YW; Tian YR; Ma RR; Song L; Zou YX; Gao P
Oncogene; 2022 Jan; 41(3):361-371. PubMed ID: 34754080
[TBL] [Abstract][Full Text] [Related]
33. The local anesthetic ropivacaine suppresses progression of breast cancer by regulating miR-27b-3p/YAP axis.
Zhao L; Han S; Hou J; Shi W; Zhao Y; Chen Y
Aging (Albany NY); 2021 Jun; 13(12):16341-16352. PubMed ID: 34126594
[TBL] [Abstract][Full Text] [Related]
34. Increased
Qadir J; Riaz SK; Taj K; Sattar N; Sahar NE; Khan JS; Kayani MA; Haq F; Arshad Malik MF
Future Oncol; 2021 Jul; 17(21):2725-2734. PubMed ID: 33880946
[TBL] [Abstract][Full Text] [Related]
35. Dermatopontin, a shell matrix protein gene from pearl oyster Pinctada martensii, participates in nacre formation.
Jiao Y; Wang H; Du X; Zhao X; Wang Q; Huang R; Deng Y
Biochem Biophys Res Commun; 2012 Aug; 425(3):679-83. PubMed ID: 22842462
[TBL] [Abstract][Full Text] [Related]
36. MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway.
Liu W; Huang Y; Wang D; Han F; Chen H; Chen J; Jiang X; Cao J; Liu J
Oncogene; 2021 Jul; 40(26):4468-4485. PubMed ID: 34108620
[TBL] [Abstract][Full Text] [Related]
37. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
[TBL] [Abstract][Full Text] [Related]
38. Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation.
Wei C; Li X
BMC Cancer; 2020 Oct; 20(1):1042. PubMed ID: 33121449
[TBL] [Abstract][Full Text] [Related]
39. STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.
Zheng L; Xiang C; Li X; Guo Q; Gao L; Ni H; Xia Y; Xi T
J Hematol Oncol; 2018 May; 11(1):72. PubMed ID: 29848346
[TBL] [Abstract][Full Text] [Related]
40. SHISA3, an antagonist of the Wnt/β-catenin signaling, is epigenetically silenced and its ectopic expression suppresses growth in breast cancer.
Shahzad N; Munir T; Javed M; Tasneem F; Aslam B; Ali M; Mutahir Z; Akhtar Ali M; Umer M; Ahmad M; Farooq K; Hassan U; Mustafa T; Anjum RS; Shakoori AR
PLoS One; 2020; 15(7):e0236192. PubMed ID: 32692756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
